Share This Page
Drug Price Trends for NDC 00093-1138
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-1138
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ACITRETIN 17.5 MG CAPSULE | 00093-1138-56 | 10.30014 | EACH | 2025-04-23 |
| ACITRETIN 17.5 MG CAPSULE | 00093-1138-56 | 10.13984 | EACH | 2025-03-19 |
| ACITRETIN 17.5 MG CAPSULE | 00093-1138-56 | 10.88024 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-1138
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Pharmaceutical Industry: A Comprehensive Overview
Introduction
The pharmaceutical industry is a complex and dynamic sector, influenced by various factors including regulatory changes, technological advancements, and market demand. This article will delve into the current trends, market analysis, and price projections within the pharmaceutical industry, providing insights that are crucial for business professionals aiming to transform data into market domination.
National Drug Code (NDC) Directory: Understanding the Basics
The National Drug Code (NDC) Directory, maintained by the FDA, is a critical resource for identifying and tracking drug products in the U.S. market. Each drug is assigned a unique three-segment NDC number, which serves as the FDA’s identifier for drugs. The directory includes information on finished, unfinished, and compounded drug products, including prescription, over-the-counter, approved, and unapproved drugs[1][5].
Current Market Trends in the Pharmaceutical Industry
Data-Driven Transformation
The pharmaceutical industry is shifting towards a data-centric approach, leveraging advanced technologies to optimize research and development processes. This includes integrating data from multiple sources to enhance productivity and competitiveness. Centralized systems and real-time analytics are key components of this transformation, enabling companies to make data-driven decisions and stay ahead in innovation[3].
Specialty Pharmaceuticals
Specialty pharmaceuticals, which treat high-cost, complex, or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions, are driving significant market growth. These medications make up the majority of the top spend categories among pharmacy program participants. For instance, weight loss drugs like semaglutide and tirzepatide are seeing dramatic increases in spending and utilization[2].
Biosimilars and Generic Drugs
Biosimilars are expected to grow in market share, particularly as pharmacy benefit managers finalize their formulary strategies. While Humira still dominates the adalimumab market, biosimilar products are anticipated to gain significant ground in 2024. Generic drugs, especially those resulting from patent expirations of blockbuster drugs, will also impact market dynamics. For example, the patent expiration of drugs like Tarceva and Alimta will lead to increased generic sales, affecting the overall market growth[2][4].
Price Projections and Market Analysis
Overall Price Inflation
Vizient projects a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals. This is the highest projected increase since July 2019, with weight loss drugs and the expansion of gene therapies contributing significantly to this rise[2].
Specialty Drug Market
In the non-small cell lung cancer (NSCLC) market, premium-priced immune checkpoint inhibitors and targeted therapies are expected to drive growth. Drugs like Keytruda, Opdivo, and Tecentriq will achieve blockbuster status by 2025, with collective sales projected to reach $17.5 billion. Targeted therapies, such as Tagrisso and Avastin, will also see substantial sales growth, with Tagrisso projected to achieve $1.7 billion in sales by 2025[4].
Impact of Generic and Biosimilar Drugs
The entry of generic and biosimilar drugs will influence market dynamics. For instance, the sales of generic erlotinib and pemetrexed are expected to rise significantly following the patent expiration of Tarceva and Alimta. Biosimilars, despite their lower price points, are expected to increase in market share, particularly as they become more accepted and mandated by payers[2][4].
Case Study: NDC 00093-1138
While specific price projections for the NDC 00093-1138 are not provided in the available sources, understanding the broader market trends can offer insights into potential price movements.
- Specialty Drug Influence: If the drug falls under the category of specialty pharmaceuticals, it is likely to be affected by the overall trend of increasing prices in this segment.
- Generic and Biosimilar Impact: If the drug has generic or biosimilar counterparts, the market dynamics could shift towards lower prices as these alternatives gain market share.
- Regulatory and Technological Factors: The drug's pricing could also be influenced by regulatory changes, such as updates to the NDC Directory, and technological advancements that improve manufacturing efficiency or patient outcomes.
Key Drivers of Price Increases
Weight Loss and Anti-Obesity Medications
The increased utilization of weight loss drugs, such as GLP-1 agonists like semaglutide and tirzepatide, is a significant driver of price increases. These medications have risen rapidly in total spend, indicating a strong market demand and potential for continued price growth[2].
Gene Therapies and Immunotherapies
The expansion of gene therapies and the increasing use of immunotherapies in treatments like NSCLC are driving up provider spend. These therapies are often high-cost and complex, contributing to the overall increase in drug prices[2][4].
Supply Chain and Regulatory Factors
Managing pharmacy expenditures and strengthening the supply chain are critical due to drug shortages and rising costs. Regulatory updates, such as those reflected in the NDC Directory, also play a role in ensuring that all listed drugs are accurately tracked and priced[1][2].
Future Outlook and Challenges
Unmet Needs and Market Opportunities
Despite the growth in certain segments, there are still unmet needs in the market, particularly in areas like NSCLC where new treatments are being developed. Companies that can address these needs through innovative products and data-driven strategies are likely to dominate the market[4].
Technological Advancements
The integration of advanced technologies, such as AI and smart manufacturing, will continue to shape the pharmaceutical industry. These technologies can improve R&D efficiency, enhance patient care, and optimize pricing strategies[3].
Conclusion
The pharmaceutical industry is navigating a complex landscape of technological advancements, regulatory changes, and shifting market demands. Understanding these trends and their impact on pricing is crucial for business professionals aiming to transform data into market domination.
Key Takeaways
- The pharmaceutical industry is moving towards a data-driven approach to improve health outcomes and reduce costs.
- Specialty pharmaceuticals, particularly those treating chronic and complex conditions, are driving significant market growth and price increases.
- Biosimilars and generic drugs will continue to influence market dynamics, especially as patents expire and formulary strategies evolve.
- Technological advancements and regulatory updates will play critical roles in shaping the industry’s future.
FAQs
What is the National Drug Code (NDC) Directory?
The NDC Directory is a resource maintained by the FDA that contains information about finished, unfinished, and compounded drug products, each identified by a unique three-segment NDC number[1][5].
How are specialty pharmaceuticals impacting the market?
Specialty pharmaceuticals are driving significant market growth and price increases due to their high cost and the increasing utilization in treating complex and chronic conditions[2].
What role do biosimilars play in the pharmaceutical market?
Biosimilars are expected to grow in market share, particularly as they become more accepted and mandated by payers, offering lower-cost alternatives to originator products[2].
How are technological advancements influencing the pharmaceutical industry?
Technological advancements, such as AI, smart manufacturing, and data integration, are improving R&D efficiency, enhancing patient care, and optimizing pricing strategies[3].
What are the key drivers of price increases in the pharmaceutical market?
Key drivers include the increased utilization of weight loss and anti-obesity medications, the expansion of gene therapies and immunotherapies, and supply chain and regulatory factors[2][4].
Sources
- YouTube: NDC Directory (March 2015) - YouTube
- Vizient Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
- Bismart: Pharmaceutical Industry Trends 2024 - 2025
- Drug Development: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
- FDA: National Drug Code Directory - FDA
More… ↓
